Regeneron Pharmaceuticals (REGN) Dividend History & Analysis
Track McKesson's (REGN) dividend history - current yield, annual dividend growth rate, payout history and peer comparisons.
Yield 12m
0.11%
Dividends per Share 12m
0.88
Dividend Growth Rate 5y
-
Overall Dividend Rating
1.00%
Yield on Cost 5y
0.17%
Payout Ratio
1.9%
Payout Frequency 12m
1
Payout Consistency
1.0%
Total Return 12m: -34.39%
#75 in Group
Total Return 5y: 24.22%
#38 in Group
Dividends Cash Amount per Share Yearly
Number of Payouts Yearly
5 Years Chart with Price and Dividend Yield
Top Dividend Payers in Biotechnology
Similar Stocks with Attractive Dividends
ABBV
AMGN
NOVO-B
SECARE
REGN Dividend History: Last 1 Payments (USD)
| Ex-Dividend Date | Record Date | Payment Date | Period | Dividend per Share | Dividend Growth Rate | Payout Yield |
|---|---|---|---|---|---|---|
| 2025-02-20 | 2025-02-20 | 2025-03-20 | Quarterly | 0.88 | 0.13% |
REGN Dividend FAQ
Does REGN pay dividends?
Yes, as of April 2025, REGN paid a dividend of 0.88 USD in the last 12 months. The last dividend was paid on 2025-02-20.What is the Dividend Yield of REGN?
As of April 2025, REGN`s dividend yield is 0.11%. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of 880K USD by the current share price of 625.60.How often does REGN pay dividends?
REGN pays dividends annually. Over the last 12 months (TTM), REGN has issued 1 dividend payments.What is the next Ex-Dividend Date for REGN?
The next ex-dividend date for Regeneron Pharmaceuticals (REGN) is unknown.What is the Dividend Growth of REGN?
REGN's average dividend growth rate over the past 5 years is -% per year.
What is the Yield on Cost of REGN?
REGN's 5-Year Yield on Cost is 170K%. This represents the effective dividend yield for an investor who bought Regeneron Pharmaceuticals five years ago. It is calculated as the sum of all trailing 12-month dividends (880K) divided by the purchase price five years ago (503.62):What is the Payout Consistency of REGN?
REGN Payout Consistency is 1.0%.
Highly unstable: Regeneron Pharmaceuticals has a poor track record of consistent dividend payments.